CATHOLIC UNIVERSITY OF DAEGU INDUSTRY ACADEMIC COOPERATION FOUNDATION
发明人:
HONG, JOO HEONKR,홍주헌,LEE, DAE HOONKR,이대훈,YANG, SU JINKR,양수진,KANG, EUN JIKR,강은지,PARK, HYE MIKR,박혜미,KIM, DAE DONGKR,김대동,SHIN, JIN HAKR,신진하,KWAK, MIN JINKR,곽민진
申请号：
KR1020130007212
公开号：
KR1020140094775A
申请日:
2013.01.23
申请国别(地区):
KR
年份:
2014
代理人:
摘要：
The present invention provides a pharmaceutical composition for preventing and treating cancer or inflammation, wherein the pharmaceutical composition contains any one selected from water-soluble chitosans having molecular weights of 8 kDa, 43 kDa, or 67 kDa as an active ingredient by inspecting anti-oxidation, anti-cancer, and anti-inflammation effects of each of the water-soluble chitosans according to the molecular weight.COPYRIGHT KIPO 2014본 발명은 수용성 키토산의 분자량에 따른 각각의 항산화, 항암, 항염증 효과를 검정함으로써 분자량이 8kDa, 43kDa 또는 67kDa 수용성 키토산 중 선택되는 어느 하나를 유효성분으로 함유하는 암 또는 염증 예방 및 치료용 약학적 조성물을 제공한다.
